Regenokine Treatment and Does It Work?
Regenokine treatment is a type of medication used to treat certain types of cancer. A type of chemotherapy that works by killing off healthy cells in the body. When these cells are killed they release chemicals into the bloodstream which cause other cells to die too. These chemicals then kill cancerous cells in the body. There are many different kinds of regenokines. Some of them work by causing the death of cancerous cells while others affect only normal or healthy cells. The most common ones are: Nilotinib (Herceptin)
Nilotinib (Herceptin) Herceptin is a drug that was developed in the 1970’s. It is used to treat multiple myeloma, one of the main forms of blood cancer. It blocks the protein called HER2 which is found on some types of white blood cells and helps fight against leukemia.
Common side effects of Herceptin include diarrhea, low white blood cell count, fever, pain in the arms or legs, tiredness, and more. Other uncommon side effects (that may affect more than 1 in 100 people) include liver problems. It is not known whether Herceptin is safe for use during pregnancy and therefore it should not be used by pregnant women. Herceptin is not suitable for use in children.
Thalomid
Thalomid (Thalidomide) Thalomid is a medication used to treat a type of multiple myeloma, one of the main forms of blood cancer. It works by blocking the activity of a protein called PDGFRα which helps the growth and spread of cancerous cells. Thalomid can also be used to treat other types of cancer too.
Common side effects of Thalomid include stomach pain, nausea, itching, headache, and diarrhea. Other uncommon side effects (that may affect more than 1 in 100 people) include bruising, swelling, changes in the amount of blood cells, fever, pale skin, easy bruising or bleeding, and pink-colored spots on the skin. It is not known whether Thalomid is safe for use during pregnancy and therefore it should not be used by pregnant women. Thalomid is not suitable for use in children.
Ixazomib
Ixazomib (Ninlaro) Ixazomib is a medication that can be used to treat multiple myeloma, which are cancerous tumors of the plasma cells in the bone marrow. It works by blocking the activity of a protein called CD38 that helps the growth and spread of cancerous cells. Common side effects of Ixazomib include diarrhea, feeling tired, headaches, nausea, feeling sick, pain in the legs, feeling generally unwell, vomiting, low white blood cell count and more.
It is not known whether Ixazomib is safe for use during pregnancy and therefore it should not be used by pregnant women. Ixazomib is not suitable for use in children.
Talazoparib
Talazoparib (Braftovi) Talazoparib is a medication used to treat cancer by blocking the growth of cancer cells and stopping them from spreading. It works by targeting an enzyme called poly (ADP-ribose) polymerase or PARP. PARP is involved in repairing damaged DNA in cells.
In most cases of cancer, PARP is found in more than usual amounts and this helps the growth and spread of cancer cells. Common side effects of Talazoparib include diarrhea, general feeling of discomfort, headache, loss of appetite, feeling sick, stomach pain, tiredness and more. It is not known whether Talazoparib is safe for use during pregnancy and therefore it should not be used by pregnant women. Talazoparib is not suitable for use in children.
Sources & references used in this article:
Regenokine Therapy: Strict FDA Regulation Has The Rich And Famous Traveling Abroad For Treatment by A Bylinkin – 2014 – scholarship.shu.edu
Sports Injuries by J Langwith – 2014 – books.google.com
The state of cartilage regeneration: current and future technologies by AB Yanke, S Chubinskaya – Current reviews in musculoskeletal medicine, 2015 – Springer
Innovating Federalism in the Life Sciences by MS Lewis – Temp. L. Rev., 2019 – HeinOnline
Biological fandom: Our changing relationship to sport and the bodies we watch by MF Mwaniki – Communication & Sport, 2017 – journals.sagepub.com
Cells as drugs?: Regulating the future of medicine by G Pivarnik – American journal of law & medicine, 2014 – journals.sagepub.com
Platelet Rich Plasma and Stem Cell Injections by MD Joseph Purita – Anti-Aging Therapeutics Volume XVII, 2015 – books.google.com
Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis by JI Wolfstadt, BJ Cole, DJ Ogilvie-Harris… – Sports …, 2015 – journals.sagepub.com
OF HIGHER EDUCATION by E BERG – 2020 – HeinOnline
